Of the US$15bn annual funding for TB promised by world leaders at the UN High-Level Meeting 2018, about 40% has been made available. This #WorldTBDay, we call on leaders to step up and triple the funding to save lives and #EndTB by 2030. #InvestToEndTB
Please check out my #WorldTBDay message-spotlighting the urgent need to dramatically increase investments to ramp up the TB response to end #TB deaths & suffering, especially for the most vulnerable #InvestToEndTB#SaveLives https://t.co/UQg8KQDj5o
We're excited to announce our parent company, @OliluxB's, new partnership with the @R2D2_TBnetwork. Read about our fight against drug resistant #tuberculosis here: https://t.co/TvxhabJj5J
#JoinUs for a special #EndTB Webinar on 2 March hosted by @WHO, @Refugees & @CDC_TB to launch an Interagency field guide on #TB prevention & care among refugees & other populations in humanitarian settings. Register here👉https://t.co/V6bBYJeyfV #EndTB#LeaveNoOneBehind
Preventing TB for those most at risk of falling ill is a great way to #InvestLoveToEndTB. This #ValentinesDay ♥️ we invite you to send good wishes and messages of love💌 to everyone around the world fighting TB. Post your message here https://t.co/8ot5BiymOo
#CheckOut our comprehensive #LookBack at #EndTB efforts over 2021. I'd like to thank you all for your solidarity,commitment&dedicated work in these difficult times towards saving the lives of millions w/ #TB. Looking forward w/ hope for a successful 2022. https://t.co/57b3NZrEGB
Funding for #tuberculosis research is an integral part of the fight against #TB. It would be impossible to reach the @WHO End TB Strategy milestones without additional dedicated resources!
New report from @TAGTeam_Tweets + @StopTB states that 2020 funding for #TB research was less than half of $2B goal & less than 1% of R&D investment in #COVID19.
Read the full report: https://t.co/5pEdGGUrE8
Pleased to brief @WHO Member States at Special Mission Briefing on status of #EndTB Progress and the Global strategy for #tuberculosis research and innovation. Call for urgency and action as we race to reach 2022 targets amidst challenges due to the #COVID19 pandemic. #EndTB
This #WorldAIDSDay we recognize the connection b/w #HIV & #TB. People with weakened immune systems have a much greater risk of falling ill from TB. People living with HIV are 20 - 30 X more likely to get TB, and TB is the leading cause of death among people living with HIV.
Today on International Day to End Violence against Women🌎we stand in solidarity with women everywhere; no women should be subject of physical or psychological violence - including that resulting from their TB status.
#OrangeTheWorld#GenerationEquality
Only 1️⃣ in 3️⃣ people with drug-resistant #tuberculosis are known to be getting the treatment they need.
We need to expand access to WHO-recommended fully-oral treatment regimens that improve treatment outcomes and save lives. Spread Awareness. Stop Resistance.
#AMR#WAAW
Congratulations @paimadhu! We had the wonderful opportunity to meet and learn from you during the @mcgillu Summer Institute a few years ago, and it remains a highlight in our fight against #tuberculosis#TB.
😷 In an interview with Ruby E Dewi, General Manager of @MediLuxB we shed on light tuberculosis’s prevalence in Asia and how we can reduce the burden of infectious diseases through innovative breakthrough like their novel dye.🦠
https://t.co/VP8D2lUoyV
@OliluxB' co-founder and CEO, @MireilleKamariz, was recently interviewed for the @thermofisher@AlfaAesar Chemistry Podcast Series: Conversations with C&EN's Talented 12. Check out her interview on Season 2 Episode 10.
https://t.co/naIiti2G8f
We're so excited to share our interview with @asia_biotech! Get to know us, our technology, our parent company @OliluxB, and our fight against #tuberculosis#TB in the latest APBN issue! We're establishing new collaborations in the region - reach out to us if you're interested!
We also have Ruby E Dewi from MediLux Biosciences sharing their latest dye that’s expected to revolutionise tuberculosis diagnosis and Dr Galileo Violini presenting Italy's contagion data and assessing if its R-value is linked to vaccination rates.💉🦠
https://t.co/iJStELcZuJ
Innovation designed for low resource settings is a key, but often overlooked, aspect of the fight against #tuberculosis#TB. We're excited to see new tools, such as these ventilators, being developed.
Designed in response to a ventilator shortage because of #COVID19, the @ImperialBioeng@ImperialSandC team behind @JAM_VENT are now aiming to tackle the myriad of other respiratory conditions, such as #TB#tuberculosis and #flu all around the world: https://t.co/SJXGmEkRwn
So many lessons learned from the #COVID19 pandemic can be applied to the fight against #tuberculosis - including the development of effective vaccines and rapid & accurate diagnostics!
Congratulations on the inaugural issue, @PLOSGPH! We're particularly excited about the article on applying lessons from neglected tropical diseases to battle #tuberculosis!
Exciting news: we've published our initial cohort of papers! We invite you to explore our first published articles in a variety of research areas, including Infectious Diseases, Global Health Delivery, Laboratory Medicine, and more.
#OpenScience#OpenAccess#GlobalPublicHealth